[go: up one dir, main page]

GB201421933D0 - Method for a detection of hormone sensitive diease progression - Google Patents

Method for a detection of hormone sensitive diease progression

Info

Publication number
GB201421933D0
GB201421933D0 GBGB1421933.1A GB201421933A GB201421933D0 GB 201421933 D0 GB201421933 D0 GB 201421933D0 GB 201421933 A GB201421933 A GB 201421933A GB 201421933 D0 GB201421933 D0 GB 201421933D0
Authority
GB
United Kingdom
Prior art keywords
diease
progression
detection
hormone sensitive
hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1421933.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Singapore Volition Pte Ltd
Original Assignee
Singapore Volition Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Singapore Volition Pte Ltd filed Critical Singapore Volition Pte Ltd
Priority to GBGB1421933.1A priority Critical patent/GB201421933D0/en
Publication of GB201421933D0 publication Critical patent/GB201421933D0/en
Priority to EP15813493.2A priority patent/EP3230742A1/en
Priority to PCT/GB2015/053776 priority patent/WO2016092306A1/en
Priority to CA2970186A priority patent/CA2970186A1/en
Priority to AU2015359062A priority patent/AU2015359062A1/en
Priority to SG11201704642WA priority patent/SG11201704642WA/en
Priority to US15/534,967 priority patent/US20170336422A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB1421933.1A 2014-12-10 2014-12-10 Method for a detection of hormone sensitive diease progression Ceased GB201421933D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB1421933.1A GB201421933D0 (en) 2014-12-10 2014-12-10 Method for a detection of hormone sensitive diease progression
EP15813493.2A EP3230742A1 (en) 2014-12-10 2015-12-10 Method for the detection of hormone sensitive disease progression
PCT/GB2015/053776 WO2016092306A1 (en) 2014-12-10 2015-12-10 Method for the detection of hormone sensitive disease progression
CA2970186A CA2970186A1 (en) 2014-12-10 2015-12-10 Method for the detection of hormone sensitive disease progression
AU2015359062A AU2015359062A1 (en) 2014-12-10 2015-12-10 Method for the detection of hormone sensitive disease progression
SG11201704642WA SG11201704642WA (en) 2014-12-10 2015-12-10 Method for the detection of hormone sensitive disease progression
US15/534,967 US20170336422A1 (en) 2014-12-10 2015-12-10 Method for the detection of hormone sensitive disease progression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1421933.1A GB201421933D0 (en) 2014-12-10 2014-12-10 Method for a detection of hormone sensitive diease progression

Publications (1)

Publication Number Publication Date
GB201421933D0 true GB201421933D0 (en) 2015-01-21

Family

ID=52425731

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1421933.1A Ceased GB201421933D0 (en) 2014-12-10 2014-12-10 Method for a detection of hormone sensitive diease progression

Country Status (7)

Country Link
US (1) US20170336422A1 (en)
EP (1) EP3230742A1 (en)
AU (1) AU2015359062A1 (en)
CA (1) CA2970186A1 (en)
GB (1) GB201421933D0 (en)
SG (1) SG11201704642WA (en)
WO (1) WO2016092306A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019023651A2 (en) 2017-07-28 2019-01-31 Massachusetts Institute Of Technology Small molecule modulators of the androgen receptor
WO2019023654A2 (en) * 2017-07-28 2019-01-31 Massachusetts Institute Of Technology Discovery of small molecules that target the androgen receptor and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4092415A1 (en) * 2011-12-07 2022-11-23 Belgian Volition Srl Method for detecting nucleosome adducts
WO2014047285A1 (en) * 2012-09-19 2014-03-27 Paraskevi Giannakakou Identifying taxane sensitivity in prostate cancer patients
GB201303576D0 (en) * 2013-02-28 2013-04-10 Singapore Volition Pte Ltd Method for predicting therapy efficacy using nucleosome structure biomarkers

Also Published As

Publication number Publication date
SG11201704642WA (en) 2017-07-28
WO2016092306A1 (en) 2016-06-16
CA2970186A1 (en) 2016-06-16
EP3230742A1 (en) 2017-10-18
AU2015359062A1 (en) 2017-06-29
US20170336422A1 (en) 2017-11-23

Similar Documents

Publication Publication Date Title
GB2522781B (en) Mark detecting method
GB201423327D0 (en) Method for determining the position of a portable device
GB201508565D0 (en) Detecting camera conditions
GB201407840D0 (en) A method of testing an optical sensor
GB2529888B (en) A method of image analysis
GB2530816B (en) Method for determining location of wireless devices
GB201408100D0 (en) Detection method
IL247768A0 (en) Apparatus and method for detecting a presence of cancer
ZA201702898B (en) Method for measuring reactivity of fviii
GB201607639D0 (en) Sensing method
PL3239588T3 (en) Method for detecting a substance
PL3589742T3 (en) Method of detection
GB2522663B (en) A method of selecting a region of interest
GB201405203D0 (en) Detecting apparatus
GB201807651D0 (en) A method of detection
GB2523659B (en) Method and device for determining a distance of a vehicle from a traffic-controlling object
GB201611652D0 (en) Method of detecting a condition
EP3299837C0 (en) Proximity detection method
GB2522259B (en) A method of object orientation detection
GB201416459D0 (en) Detection method
GB201406707D0 (en) In-bottle detection method
GB201419330D0 (en) Detection method
GB201421933D0 (en) Method for a detection of hormone sensitive diease progression
GB201408120D0 (en) A device for determining unconciousness of a subject and a device for detecting a fall by a subject
IL247270A0 (en) Method of detecting cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)